Role of Red Ginseng in Improving Clinical Global Impression in Patients with Chronic Pancreatitis with Minimal Symptoms

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0009681

Enrollment

Registered

2024-08-05

Start date

2024-04-18

Completion date

Unknown

Last updated

2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Dietary Supplement : Red ginseng tablets were dispensed to each enrolled participant, composed of Ginsenoside Rb1, Rg1 and Rg3. Dose of each tablet was 500 milligram, and patients were educated to tak

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: ? Patients diagnosed with chronic pancreatitis. ? Patients with mild symptom (CGI score 0 or 1) ? Patients older than 18

Exclusion criteria

Exclusion criteria: ? Patient incapable of comprehending details of consent form ? Patient requiring addictive medication or invasive procedure due to aggravated symptom ? Patient with allergic history related to Red ginseng ? Patient with life expectancy estimated shorter than 6 months ? Patient with history of drug abuse ? Patient formerly diagnosed with pregnant as well as any possible pregnant

Design outcomes

Primary

Measure	Time frame
Clinical Global Impression (CGI)	—

Secondary

Measure	Time frame
Pancreatic Exocrine Insufficiency Questionnaire (PEI-Q) score;Adverse event	—

Countries

Korea, Republic of

Contacts

Public ContactJOONGYU KANG

Seoul National University Hospital

jgkang94@gmail.com+82-2-2072-2228

Outcome results